Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc
Bullboard Posts
User Avatar Image
(77)
•••
Comment by GorgeousGeorge1on Feb 12, 2019 2:11pm
124 Views
Post# 29354125

RE:RE:RE:RE:RE:RE:RE:Anyone know when we are going to actually get clinical news?

RE:RE:RE:RE:RE:RE:RE:Anyone know when we are going to actually get clinical news?Good, thanks for clearing that up. I had compared the pdf from the January JPMorgan presentation to the one from yesterday. In January they estimated Q1 19 - phase 2 clinical results with Merck in DBLC and ovarian, and the timeline graphic showing the two at equal progress. Yesterday's milestone targets doesn't mention ovarian results, and the timeline graphic shows its progress as equal to the basket trial. Apologies for causing alarm.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities